NCT04481672View on ClinicalTrials.gov

Intravenous Magnesium in Patients Receiving Cisplatin

PHASE1CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

July 30, 2021

Primary Completion Date

December 30, 2021

Study Completion Date

December 30, 2021

Conditions
Mesothelioma
Interventions
DRUG

Magnesium Sulfate

Intravenous infusion of magnesium sulfate prior to intraoperative chemotherapy with cisplatin.

Trial Locations (1)

02215

Brigham and Women's Hospital, Boston

All Listed Sponsors
lead

Dana-Farber Cancer Institute

OTHER

NCT04481672 - Intravenous Magnesium in Patients Receiving Cisplatin | Biotech Hunter | Biotech Hunter